Immunogenicity of the hu14.18-IL2 immunocytokine molecule in adults with melanoma and children with neuroblastoma
about
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo.Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.Cytokines in cancer immunotherapy.Glycans as targets for therapeutic antitumor antibodies.Immunocytokines: a review of molecules in clinical development for cancer therapy.Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
P2860
Q33597441-3947055A-63ED-4149-A709-CDDA6751B470Q34488726-AEB6FE2F-2BB2-411C-9D44-F121457CA264Q36057459-D21976A3-A044-498F-94BF-A19BB7D39BACQ36412879-B823E3B1-200C-41AE-87B8-2E9917D91BDFQ37148152-0BD1DB1C-990F-437B-BE5C-ACD2F54B98A3Q38034815-E940C00C-6A75-44D3-8B6E-A3B4EF666CBCQ38132742-352FD4C0-8127-46D5-AAAB-12917DB0BE14Q38903708-56A12937-C25F-4F69-BCF4-E6E378340D13Q38916529-4BE18468-FDF8-4819-B335-DA26E96AFA20Q39110347-84E5EE28-0EFF-46CF-AB0C-79C9FE9E5226Q50034069-53F8B048-3A4B-48E1-8C00-3D7DC434A0BC
P2860
Immunogenicity of the hu14.18-IL2 immunocytokine molecule in adults with melanoma and children with neuroblastoma
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Immunogenicity of the hu14.18- ...... nd children with neuroblastoma
@en
Immunogenicity of the hu14.18- ...... d children with neuroblastoma.
@nl
type
label
Immunogenicity of the hu14.18- ...... nd children with neuroblastoma
@en
Immunogenicity of the hu14.18- ...... d children with neuroblastoma.
@nl
prefLabel
Immunogenicity of the hu14.18- ...... nd children with neuroblastoma
@en
Immunogenicity of the hu14.18- ...... d children with neuroblastoma.
@nl
P2093
P2860
P1476
Immunogenicity of the hu14.18- ...... nd children with neuroblastoma
@en
P2093
Adam Sternberg
Amy Ostendorf
Jacquelyn A Hank
Jens Eickhoff
Kin-Ming Lo
Mark Albertini
Paul M Sondel
Stephen D Gillies
P2860
P304
P356
10.1158/1078-0432.CCR-08-2963
P407
P577
2009-09-08T00:00:00Z